Mankind Pharma Share Price
2337.30-31.50 (-1.33%)
-8.67% past 1 Year
News
Mankind Pharma exits non-core hospitality arm via Rs 49 crore stake sale
Equity
MANKIND
Mankind Pharma board approves voluntary liquidation of key subsidiary BSVL
Equity
MANKIND
Mankind Pharma gets CRISIL ESG rating upgraded to Strong category
Equity
MANKIND
Mankind Pharma signs exclusive insulin degludec and combo licensing deal in India
Equity
MANKIND
Mankind Pharma sees Rs 24.26 crores NSE block trade at Rs 2400.40
Equity
MANKIND
Mankind Pharma sees Rs 24.12 crores NSE block trade at premium price
Equity
MANKIND
Mankind Pharma sees Rs 52.14 crore NSE block trade in 216,181 shares
Equity
MANKIND
Mankind Pharma sees Rs 25.89 crores NSE block trade at Rs 2484.90
Equity
MANKIND
Mankind Pharma reports strong Q1 revenue growth on year-over-year basis
Equity
MANKIND
Mankind Pharma Q1 EBITDA jumps year on year with stronger margins
Equity
MANKIND
Mankind Pharma Q1 consolidated net profit rises sharply on strong YoY growth
Equity
MANKIND
Mankind Pharma records Rs 18.34 crores NSE block trade for 71,310 shares
Equity
MANKIND
Mankind Pharma records NSE block trade worth Rs 19.57 crores
Equity
MANKIND
Mankind Pharma sees Rs 25.51 crores NSE block deal at premium price
Equity
MANKIND
Mankind Pharma to hold Q1 earnings call on July 30
Equity
MANKIND
Mankind Pharma sees Rs 26.43Cr NSE block trade at Rs 2,519 per share
Equity
MANKIND
Mankind Pharma approves Broadway Hospitality sale, plans Netherlands R&D subsidiary
Equity
MANKIND
Jefferies retains Buy on Mankind Pharma, lifts target price to Rs 3,000
Equity
MANKIND
Mankind Pharma gains Incred add rating on R and D shift and BSV acquisition
Equity
MANKIND
Mankind Pharma rises as its arm acquires remaining 10% stake in Upakarma
Equity
MANKIND